Made Scientific Buys 85,000 Sq. Ft. Cell Therapy Plant from National Resilience
Image
Princeton – September 21, 2026 -- Made Scientific, Inc. has acquired an 85,000 sq. ft. clinical-to-commercial cell therapy manufacturing facility in East Norriton, Pennsylvania, from National Resilience, closing the transaction on September 18, 2026. The purchase expands the company's U.S. East Coast footprint to approximately 145,000 sq. ft. and 15 qualified GMP manufacturing suites across New Jersey and Pennsylvania.
Operational site eliminates greenfield ramp-up delays
The East Norriton facility is operational on close, with its manufacturing team having executed 145 GMP batches to date across autologous and allogeneic programs, including CAR-T and B-cell therapies. Made Scientific said sponsors can begin onboarding programs immediately, targeting 2027 clinical and commercial supply.